Recruiting PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT06903559

Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients (ROXA-HD-MIA)

Effect of Roxadustat on Cardiovascular System and Malnutrition-Inflammation-Atherosclerosis (MIA) Syndrome in Hemodialysis Patients: A Randomized Controlled Study

Sponsor: Mansoura University

Conditions Anemia in End Stage Renal Disease Cardiovascular Diseases (CVD) Kidney Failure, Chronic Malnutrition-Inflammation Syndrome

Interventions Conventional Anemia Management Roxadustat

Updated 3 times since 2025 Last updated: May 8, 2025 Started: Apr 15, 2025 Primary completion: Oct 15, 2025 Completion: Nov 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Anemia in End Stage Renal Disease and Cardiovascular Diseases (CVD), this trial is actively recruiting participants. The trial is conducted by Mansoura University and has accumulated 3 data snapshots since 2025. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

3 versions recorded

Sep 2025 — Present [monthly]

Recruiting PHASE1/PHASE2
Jun 2025 — Sep 2025 [monthly]

Recruiting PHASE1/PHASE2

Status: Not Yet Recruiting → Recruiting
Apr 2025 — Jun 2025 [monthly]

Not Yet Recruiting PHASE1/PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mansoura University

Data source: Mansoura University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Al Mansurah, Egypt